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MEKANISME MERENDAHKAN KOLESTEROL IN VITRO OLEH SPESIES 
LACTOBACILUS DAN BIFIDOBACTERIUM YANG TERPILIH DAN KESAN 
RAWATAN FIZIKAL 
 
ABSTRAK 
  
Lima belas spesies (Lactobacillus dan Bifidobacterium) disaring melalui ciri-
ciri pelekatan mereka. Lactobacillus acidophilus BT 1088, L. acidophilus FTCC 
0291, L. bulgaricus FTCC 0411, L. bulgaricus FTDC 1311, dan L. casei BT 1268 
menunjukkan keupayaan pelekatan yang lebih tinggi di dalam media dan justeru itu 
dipilih untuk analisis keupayaan penyingkiran kolesterol. Keupayaan penyingkiran 
kolesterol dilaksanakan secara in vitro dalam keadaan yang menyerupai saluran usus 
manusia (pH 8.0). Kajian ini memberikan bukti yang mengukuhkan hipotesis, yakni 
lactobacilli dapat menyingkirkan kolesterol melalui pelbagai mekanisme, antaranya 
termasuklah asimilasi kolesterol semasa pertumbuhan, pelekatan kolesterol pada 
membran sel, perencatan pembentukan misel kolesterol, penggabungan kolesterol ke 
dalam membran sel, dekonjugasi garam hempedu, aktiviti hidrolase garam hempedu 
(BSH), dan penukaran kolesterol kepada koprostanol.  
Antara mekanisme yang dikaji, mekanisme penggabungan kolesterol adalah 
lebih menonjol dan lokasi-lokasi kolesterol yang digabungkan juga telah dikenal 
pasti. Oleh sebab penggabungan kolesterol ke dalam membran sel melibatkan 
kebolehtelapan membran, jadi rawatan-rawatan fizikal submaut turut seperti 
ultrasonik (20-100 W; 1-3 min), elektroporasi (2.5-7.5 kV cm-1; 3-4 ms), dan sinaran 
UV (UVA-UVC, 30-90 J m-2) diaplikasikan untuk meningkatkan penyingkiran 
kolesterol oleh spesies Lactobacillus. Rawatan-rawatan fizikal ini meningkatkan 
pertumbuhan sel-sel lactobacilli semasa fermentasi (P < 0.05) dan juga meningkatkan 
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keupayaan penyingkiran kolesterol oleh lactobacilli dengan ketara (P < 0.05) melalui 
asimilasi and penggabungan kolesterol ke dalam membran sel yang disebabkan oleh 
peningkatan kebolehtelapan membran lactobacilli.  
Antara parameter yang dikaji, ultrasonik (100 W; 2 min), elektroporasi (7.5 
kV cm-1 selama 3.5 ms) dan sinaran UV (UVB; 60 J m-2) adalah lebih menonjol 
dalam peningkatan (P < 0.05) asimilasi kolesterol bagi sel-sel yang dirawat 
berbanding dengan kawalan. Memandangkan kesan-kesan positif rawatan fizikal, 
kajian ini seterusnya bertujuan untuk menilai kemungkinan pewarisan ciri-ciri 
penyingkiran kolesterol dan probiotik (keupayaan pelekatan pada usus) oleh sel-sel 
pada fasa yang berikutnya. Rawatan-rawatan fizikal ini meningkatan (P < 0.05) 
asimilasi kolesterol bagi sel-sel induk yang dirawat berbanding dengan kawalan, 
diiringi oleh peningkatan (P < 0.05; > 73.1%) penggabungan kolesterol ke dalam 
membran sel. Tambahan pula, peningkatan (>21.7%) asimilasi kolesterol juga 
diperhati dalam sel-sel pada fasa pertama. Walau bagaimanapun, ciri-ciri itu tidak 
diwarisi oleh sel-sel yang dirawat oleh ultrasonic and sinaran UV pada ketiga-tiga 
fasa yang berikutnya.   
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IN VITRO CHOLESTEROL-LOWERING MECHANISMS OF SELECTED 
LACTOBACILLUS AND BIFIDOBACTERIUM SPECIES AND EFFECTS OF 
PHYSICAL TREATMENTS  
 
ABSTRACT 
 
 
Fifteen strains of Lactobacillus and Bifidobacterium were screened based on 
their adherence property. Lactobacillus acidophilus BT 1088, L. acidophilus FTCC 
0291, L. bulgaricus FTCC 0411, L. bulgaricus FTDC 1311, and L. casei BT 1268 
showed higher adherence property compared to other strains studied and were thus 
selected for examination on cholesterol removal. Cholesterol removal ability was 
conducted in vitro, under conditions that mimic the human gastrointestinal tract (pH 
8.0). This study provided experimental evidence to strengthen the hypothesis that 
lactobacilli could remove cholesterol via different mechanisms, namely assimilation 
of cholesterol during growth, binding of cholesterol to cellular surface, disruption of 
cholesterol micelle, incorporation of cholesterol into the cellular membrane, 
deconjugation of bile salt, bile salt hydrolase (BSH) activity, and conversion of 
cholesterol to coprostanol.  
Among the mechanisms studied, cholesterol incorporation mechanism was 
more prominent and the locations of incorporated cholesterol have also been 
identified. Considering that incorporation of cholesterol into the cellular membrane 
involves membrane permeability, thus sub-lethal physical treatments such as 
ultrasound (20-100 W; 1-3 min), electroporation (2.5-7.5 kV cm-1; 3-4 ms), and UV 
radiation (UVA-UVC, 30-90 J m-2) were applied with the objective to further 
increase cholesterol removal by Lactobacillus species. These physical treatments 
increased (P < 0.05) viability of lactobacilli cells during fermentation and also 
         Abstract 
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improved the ability of lactobacilli cells to remove cholesterol significantly (P < 
0.05) via assimilation and membrane incorporation of cholesterol due to improved 
membrane permeability.  
Among the parameters studied, ultrasound (100 W; 2 min), electroporation 
(7.5 kV cm-1 for 3.5), and UV radiation (UVB; 60 J m-2) showed the most prominent 
effect in increased cholesterol assimilation of treated lactobacilli cells. Considering 
the positive effects of physical treatment, this study further aimed to evaluate the 
possible inheritance of cholesterol removal and probiotic properties (intestinal 
adherence ability) by subsequent passages of treated lactobacilli cells. These physical 
treatments affected the intestinal adherence ability of treated lactobacilli cells but 
increased (P < 0.05) their cholesterol assimilation compared to that of the control, 
accompanied by increased (P < 0.05) incorporation of cholesterol into the cellular 
membrane. Additionally, an increase (> 21.7%) in assimilation of cholesterol was 
also observed for the first passage of electroporated lactobacilli cells. However, such 
traits were not inherited by the subsequent three passages of ultrasound- and UV-
treated lactobacilli cells. 
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1.1 Background 
 
1.1.1 Probiotics and general benefits  
 
Lactobacilli and bifidobacteria are the most common adjunct cultures in 
fermented dairy products and have been widely associated with probiotic properties. 
Probiotics have been defined by the FAO/WHO as “viable microorganisms which 
when administered in adequate amounts confer a health benefit to the host” 
(FAO/WHO, 2001). The interest in lactobacilli and bifidobacteria has consistently 
increased due to awareness of the benefits for gut health and disease prevention and 
therapy. In addition to gut health, strains of lactobacilli and bifidobacteria have also 
been reported to reduce hypertension, stimulate immune response, suppress traveler’s 
diarrhea, and alleviate postmenopausal disorders (Liong, 2007).  
 
1.1.2 Cardiovascular disease and hypocholesterolemic effect of Lactobacillus 
and Bifidobacterium  
A high level of cholesterol in the blood has been associated with increased 
risks of cardiovascular diseases such as coronary heart disease and stroke. 
Cardiovascular disease is one of the most common diseases found in developing 
countries and there is an increased urgency for its management due to the increased 
occurrences annually (Ooi et al., 2010). Various dietary means have been 
implemented to reduce blood cholesterol levels, such as the reduction of high-
cholesterol foods, increasing intake of fibers, and drug interventions.  
 
Recent studies have also found that the consumption of lactobacilli could 
reduce blood cholesterol levels and improve blood lipoprotein profiles (Ooi et al., 
2010; Liong et al., 2007). A lowering effect on serum cholesterol by lactobacilli was 
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also observed when mini pig was fed with meal supplemented with lactobacilli cells 
(du Toit et al., 1998). In another study, Xiao et al. (2003) found that milk fermented 
by Bifidobacterium (B.) longum BL1 reduced serum total cholesterol, LDL 
cholesterol, and triglycerides not only reduced in rats, but also in 
hypercholesterolemia patients and healthy adults. This reduction of cholesterol in 
vivo and removal of cholesterol in vitro by lactobacilli could play an important role 
in modulating the human cardiovascular disease, where a 1% reduction in serum 
cholesterol could reduce the risk of coronary heart disease by 2-3% (Ooi and Liong, 
2010). 
 
Although positive clinical and experimental evidences have shown that 
lactobacilli and bifidobacteria could reduce serum cholesterol levels, the exact 
mechanisms still remained unclear and thus are increasingly investigated. It has been 
reported that this cholesterol removal ability might be attributed to either the 
assimilation of cholesterol by growing cells (Pigeon et al., 2002) and binding of 
cholesterol to cellular surface (Kimoto et al., 2002). Cholesterol adhered to bacteria 
cells would be less available for absorption, leading to reduced serum cholesterol 
levels. However, the in vivo occurrence of cholesterol assimilation and binding 
would involve the presence of bile and till now, no study has evaluated the effects of 
bile on the adherence of cholesterol onto cellular surface of lactobacilli cells. In 
addition, cholesterol bound onto cellular surface could also exert an inhibitory effect 
on cholesterol micelle formation in the intestines. The disruption of micelle 
formation would be another possible mechanism for reducing cholesterol levels, as 
cholesterol micelles are required to transport fatty acids through an aqueous medium 
to the intestinal mucosal surface for absorption (Cheeke, 2000). It has been 
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hypothesize that when bile salts are bound to the bacterial cell, less bile would be 
available for the formation of cholesterol micelle. To my knowledge, there has been 
no study evaluating on the disruption of cholesterol micelle by lactobacilli. 
Previous studies also reported that incorporation of cholesterol into the 
cellular membrane, deconjugation of bile via bile salt hydrolase (BSH; Liong et al., 
2007), and conversion of cholesterol to coprostanol (Ma, 2006) could be the 
mechanisms involved in cholesterol removal by lactobacilli. Cholesterol incorporated 
into the cellular envelope of lactobacilli was postulated to alter the cellular 
membrane of the organism and produced lactobacilli cells that were more robust 
towards sonication death, cellular lysis, and exhibited changes in the membrane fatty 
acid profiles (Liong and Shah, 2005a). However, to my knowledge, little information 
is available on the incorporation of cholesterol into cellular membrane of lactobacilli. 
Also, the location of the incorporated cholesterol has never been evaluated and we 
would be the first to do so. 
 
1.1.3 Effects of physical treatments on membrane permeability and cell growth 
In addition, physical treatments such as ultrasound, electroporation, and 
ultraviolet (UV) radiation have been shown to influence the permeability and 
diffusion across membranes of bacterial cells. Pitt and Ross (2003) and Ananta et al. 
(2005) reported that the low intensity and sub-lethal ultrasound treatment increased 
bacterial membrane permeability, leading to enhanced uptake of molecules and 
nutrients across the cytoplasmic membrane. In addition to ultrasound treatment, 
Loghavi et al. (2007) also found that temporary pore formations on bacteria cells 
upon electroporation could enhance nutrient diffusion and acceleration of microbial 
growth by increase cell membrane permeability. Similar observation was also 
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demonstrated by Bose and Chatterjee (1995), where the liposomal membrane 
becomes more permeabilized that subsequently increase the transportation of 
substrates in and/or out from the membrane upon UV treatment. Hortnag et al. 
(2010) also reported that the growth of Acinetobacter lwoffii increased upon UV 
exposure and has effective repair mechanisms that maintained their cell production. 
Thus, we hypothesized that physical treatments could induce permeabilization of cell 
membrane that not only increases the removal of cholesterol from medium by 
lactobacilli but also maintain the cell growth. To date, no attempt has been made to 
utilize such treatments to enhance and/or evaluate the cholesterol removal properties 
of lactobacilli, either via assimilation of cholesterol during growth or incorporation 
of cholesterol in bacterial membrane. Additionally, there has been no information on 
the sustainability of such treatments in affecting the growth, intestinal adherence, and 
cholesterol removal abilities for subsequent three passages.    
 
1.2 Aims and objectives of research 
This research aims to have a better understanding on the possible mechanisms 
of cholesterol removal by lactobacilli and the evaluation of physical treatments on 
such removal properties, to enhance and justify the cholesterol removal ability of 
lactobacilli. The sustainability of the treatments on the treated bacteria cells in 
affecting the growth, intestinal adherence and cholesterol removal abilities for three 
passages was also examined. The specific objectives of this study were: 
 
1) To screen and select strains of lactobacilli and bifidobacteria based on their 
adherence property. 
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2) To evaluate the in vitro mechanisms involved on the removal of cholesterol 
by lactobacilli. 
3) To examine the effects of physical treatments on cell viability, membrane 
properties, and possible increase in cholesterol removal ability of lactobacilli. 
4) To investigate the possible inheritance effect of physical treatments on 
lactobacilli based on their growth, intestinal adherence, and cholesterol 
removal abilities for the subsequent three passages.  
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2.1 Probiotic  
 
The human gastrointestinal tract (GIT) is a complex ecosystem that harbors a 
rich pool of diverse microflora (Goel et al., 2006). These indigenous bacteria are 
known to be potentially harmful or health promoting. The strains with beneficial 
properties are classified as probiotics (Isolauri et al., 2004). Probiotics are defined as 
“live microorganisms that confer a health benefit to the host once administered in 
adequate amounts” (FAO/WHO, 2001). Lactic acid bacteria (LAB) are among the 
most important probiotic microorganisms typically associated with the human GIT 
(Holzapfel et al., 2001). Some species of LAB, such as Lactobacillus (L.) 
acidophilus, L. delbrueckii subsp. bulgaricus, L. casei, L. fermentum, L. plantarum, 
and L. reuteri, and Bifidobacterium species have been reported as probiotics (Oh et 
al., 2000).  
 
Several traits have been identified for probiotics, namely safe for 
consumption, resistant towards acid and bile of the gastrointestinal environment, able 
to adhere to the intestinal epithelium of the hosts, possess antagonistic activity 
against pathogenic bacteria, and are able to maintain viability during storage (Lin et 
al., 2007). Many LAB could adapt and grow in the gut environment, and 
subsequently produce antimicrobial substances such as organic acids and 
bacteriocins (Guerra et al., 2007). Although the minimum effective dose to exert a 
health beneficial effect is not precisely known, it is commonly recommended that 
oral administration should exceed 109 CFU per day (De Champs et al., 2003). 
Additionally, some beneficial effects such as the improvement of lactose intolerance, 
modulation of immune system, and antihypertensive effects have also been reported 
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to depend upon enzyme activities and fermentation products of probiotics (Vinderola 
and Reinheimer, 2003). 
 
2.1.1 Lactobacillus 
Lactobacilli are generally characterized as gram-positive, non-sporeforming, 
and non-flagellated rods or coccobacilli (Gomes and Malcata, 1999). They are 
commonly found in habitats such as the mucosal membranes of humans and animals 
(oral cavity, intestine, and vagina), on plants and material of plant origin, in manure 
and man-made habitats such as sewage and fermenting or spoiling food where these 
habitats are rich with carbohydrate-containing substances. In healthy humans, 
lactobacilli are normally present in the oral cavity (103-104 CFU g-1), the ileum (103-
107 CFU g-1), and the colon (104-108 CFU g-1), and dominate in the vagina 
(Bernardeau et al., 2008). The most common Lactobacillus species isolated from the 
human intestine included L. acidophilus, L. salivarius, L. casei, L. plantarum, L. 
fermentum, L. reuteri, and L. brevis (Saito, 2004). The optimum growth temperature 
of lactobacilli is 35-40°C, however, the growth of this bacteria may also occur at 
higher temperature such as 45°C (Gomes and Malcata, 1999). 
 
2.1.2 Bifidobacterium 
Bifidobacteria are gram-positive, non-motile, non-sporeforming, and strictly 
anaerobic bacteria (Delcenserie et al., 2007).  They may differ in shapes and occur as 
short, curved rods, club-shaped rods, and bifurcated Y-shaped rods (Gomes and 
Malcata, 1999). In addition, they are generally nonpathogenic (Delcenserie et al., 
2007). They have been isolated from a number of environments such as sewage, 
anaerobic digester, and fermented milk (Hoyles et al., 2002), but they are the 
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predominant bacterial group in the normal intestinal flora of healthy breast-fed 
newborns, in which it constitutes more than 95% of the total population. However, 
this population of organisms gradually decreases in number with increasing age of 
the individual and may account for 25% of the total intestinal flora in healthy adults 
(Kheadr et al., 2007). The main species present in humans are B. adolescentis, B. 
bifidum, B. infantis, B. breve, and B. longum in the colon (Roy, 2001). Their 
optimum temperature for growth is 37-41°C, with maximum growth at 43-45°C and 
virtually no growth at 25-28°C or below (Gomes and Malcata, 1999). 
 
2.1.3 General benefits 
The presence of probiotics in the human intestine is almost universally 
accepted to be a contributing factor to a healthy well being (Roy, 2001). By 
improving the intestinal microbial balance, probiotics have been reported to exert 
beneficial physiological effects, such as inhibiting the growth of pathogenic 
microorganisms, reducing colon cancer, improving lactose intolerance, preventing 
gut inflammation, enhancing natural immunity, and reducing serum cholesterol on 
the host of all age groups (Liu et al., 2007). Therefore, many health care 
professionals such as holistic practitioners, naturopaths, chiropractors, and herbalists 
routinely use products containing lactobacilli, bifidobacteria, and other possible 
probiotics to enhance health properties (Reid et al., 2003). 
 
There are various evidences to support the verification of such effects, from 
in vitro, animal and human studies. Intestinal mucus could act as initial binding site, 
nutrient source, and matrix for the proliferation of bacteria and protecting the mucosa 
from certain microorganisms. Adherence to the intestinal epithelium and mucus is 
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closely related to the stimulation of the immune system, and adhesion to the intestinal 
mucosa is also crucial for transient colonization, an important prerequisite for 
probiotics to control the balance of the intestinal microflora (Juntunen et al., 2001). 
Probiotics are reported to be able to adhere to the small intestine and colonize it upon 
oral administration with the production of surface-active components which can 
inhibit the adhesion of other pathogenic bacteria (Pereira et al., 2003). Probiotics 
have also been found to inhibit the growth of bacterial pathogens by producing 
antimicrobial metabolites such as organic acids (acetic and lactic acids), hydrogen 
peroxide (in anaerobic environment), β-hydroxypropionaldehyde, and bacteriocins. 
The production of organic acids by probiotics subsequently reduces the pH of the 
medium and further inhibiting the growth of pathogens (Fayol-Messaoudi et al., 
2005). Bifidobacteria strains have been reported to inhibit Shiga toxin-producing 
Escherichia (E.) coli growth in vitro by producing a high concentration of acetic acid 
(56 mM) that lowered the pH of the intestine (to pH 6.75) (Asahara et al., 2004). 
 
Probiotic also serves as a source of lactase in the small intestine. Upon 
consuming products containing lactose, lactase-deficient individuals could 
experience abdominal pain, bloating, and diarrhea due to the colonic fermentation of 
lactose in the intestines that produce acid and gas. Dairy products containing 
probiotic strains have been found to enhance tolerance to lactose as compared to 
unfermented dairy products (Sander and Klaenhammer, 2001). This is due to the 
ability of probiotic strains to produce lactase or β-galactosidase, which digests the 
lactose in dairy products to glucose and galactose, thus facilitating digestion and 
alleviating intolerance (Harish and Varghese, 2006).  
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Moreover, probiotics have been found to be effective in the prevention of 
colon cancer. Several mechanisms have been postulated, namely the alteration of the 
metabolic activities of intestinal microflora, alteration of physicochemical conditions 
in the colon, binding and degradation of potential carcinogens, quantitative and/or 
qualitative alterations in the intestinal microflora incriminated in the production of 
carcinogens, production of antitumorigenic or antimutagenic compounds, and 
enhancing the immune response of the host (Harish and Varghese, 2006). In an in 
vitro study, Oatley et al. (2000) found that bifidobacteria were able to bind 
carcinogenic aflatoxin, thus rendering it unavailable for absorption in the intestinal 
tract. The consumption of diets containing viable probiotic has been also reported to 
reduce faecal β-glucuronidase activity in human (Goldin et al., 1980). β-
glucuronidase is often produced by intestinal bacteria and could hydrolyze 
glucuronide, a compound that is required to detoxify foreign compounds (Fotiadis et 
al., 2008). 
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2.2 In vitro cholesterol removal by lactobacilli and bifidobacteria1  
Cholesterol plays a major role in human heart health. High cholesterol in 
serum could lead to increase the risk factor for human cardiovascular disease. 
Lactobacilli and bifidobacteria have been used as potential cholesterol lowering milk 
additives. Past studies have indicated that the consumption of lactobacilli and 
bifidobacteria resulted in the reduction of serum cholesterol levels in humans and 
animals (Psomas et al., 2003). Several in vitro mechanisms of cholesterol removal by 
lactobacilli and bifidobacteria have been proposed and investigated. However, 
controversial results have been raised, where numerous studies have showed 
insignificant hypocholesterolaemic effects. Thus, more studies are needed to better 
understand the mechanisms involved. 
 
2.2.1 Assimilation of cholesterol by lactobacilli and bifidobacteria  
The assimilation of cholesterol by lactobacilli and bifidobacteria in the small 
intestine could reduce intestinal absorption of cholesterol (Pigeon et al., 2002). 
Lactobacilli and bifidobacteria must be viable and growing, in order to be able to 
remove or assimilate cholesterol (Piston and Gilliland, 1994). In an in vitro study, 
Tahri et al. (1995) reported that the growing cells of Bifidobacterium sp. were able to 
remove cholesterol from the fermentation broth via assimilation of cholesterol. The 
assimilation of cholesterol may be affected by the growth of bacteria in medium 
containing bile salts that are similar to those of the gastrointestinal conditions. 
However, little information is available on the effects of bile on cholesterol 
assimilation. Additionally, past studies have also shown controversial results, where 
some researches has exhibited insignificant results. Brashears et al. (1998) reported 
the both L. casei E5 and N19 showed insignificant effects on the removal of 
1 Parts of section 2.2 have been published in:  Lye, H. S., Kuan, C. Y., Ewe, J. A., et al. (2009) 
International Journal of Molecular Science, 10, 3755-3775. 
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cholesterol compared to the control. Similarly, Walker and Gilliland (1993) also 
found that the cultures of L. acidophilus ATCC 4356 could not remove cholesterol 
from the medium. Therefore, further assessment of this mechanism is needed to 
better understand the pathways involved and to justify the positive results obtained. 
 
2.2.2 Binding of cholesterol to bacterial cells 
Using in vitro experiments, Liong and Shah (2005a) reported that cholesterol 
could be removed from medium by lactobacilli and bifidobacteria not only through 
assimilation during growth, but also through binding of cholesterol to the cellular 
surface. This mechanism was proposed when non-growing cells and dead cells were 
found to remove cholesterol. In addition, Taranto et al. (1997) showed that about 
20% of cholesterol that was removed and bound to the cellular surface. Meanwhile, 
Dambekodi and Gilliland (1998) also reported that cholesterol was attached to the 
cell surface, upon determination of cholesterol content of the membrane fraction of 
B. longum. This mechanism is important as some products such as yoghurt and lassi 
may not contain viable cells, unless labeled otherwise. 
 
2.2.3 Disruption of micelle formation 
Formation of micelle is essential in the digestion and absorption of lipids. 
Bile salts are amphiphatic molecules with a planar hydrophobic moiety enabling 
them to penetrate into bile bilayers. Cholesterol is solubilized in the presence of bile 
and phopholipids, forming micelle in aqueous solutions (Van de Heijning et al., 
1994). Micelles are cylindrical in shape, with bile salts on the outside with their 
hydrophilic portions oriented outward while various insoluble molecules form the 
inner part (Johnson and Byrne, 2003). Disruption of micelle formation may play an 
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important role in the removal of intestinal cholesterol. Micelles are the reservoir and 
transport vehicles for cholesterol across the small intestines, and facilitate the uptake 
of monomeric cholesterol by enterocyte (Wang, 2003). The formation of micelle may 
be affected by different bile salts as bile salts are essential for the formation of 
micelle. However, up to date, little information is available on the effect of bile and 
lactobacilli towards the disruption of cholesterol micelles. Therefore, further studies 
are required to elucidate this matter. 
 
2.2.4 Incorporation of cholesterol into the cellular membrane 
Other researchers have suggested that the incorporation of cholesterol into 
cellular membrane could be another mechanism to reduce cholesterol from medium. 
Razin (1975) found that most of the cholesterol from the medium was incorporated 
into the cytoplasmic membrane, however, the outer membranes of the intact cells are 
more easily accessed by cholesterol. There was twice the amount of cholesterol in 
the protoplast membranes than that of intact cells. This indicated cholesterol could be 
preferentially bound to the cytoplasmic membranes (Tani et al., 1993). In a previous 
study, Noh et al. (1997) found that cholesterol uptake by L. acidophilus ATCC 
43121 occurred during growth. However, most assimilated cholesterol recovered 
from the cells was not metabolically degraded. Therefore, the authors suggested that 
the removal of cholesterol may also due to the ability of L. acidophilus ATCC 43121 
to incorporate cholesterol into cellular membranes during growth. In addition, Liong 
and Shah et al. (2005b) reported differences in fatty acid distribution patterns for 
cells grown with or without cholesterol. The authors found that lower amount of total 
saturated fatty acids and higher amount of total unsaturated fatty acids were 
recovered from cells grown in medium containing cholesterol compared to those in 
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the absence of cholesterol. This was attributed to the incorporation of cholesterol into 
the membrane rather than cellular synthesis because LAB living under fatty 
conditions might lose their ability to synthesize lipids or fatty acids (Kiatpapan et al., 
2001). Cholesterol that is incorporated into bacterial cells during growth in the small 
intestine is less absorbed into the enterohepatic circulation, thus could lead to 
reduced serum cholesterol in humans. We postulate that the cholesterol incorporated 
into cell membrane may affect the lipid order in lactobacilli membrane. Thus, further 
evaluation is required to support this hypothesis.   
 
2.2.5 Enzymatic deconjugation of bile salts 
Another hypocholesterolaemic mechanism that was postulated involved the 
ability of certain lactobacilli and bifidobacteria to deconjugate bile acids 
enzymatically. Deconjugation of conjugated bile salt to deconjugated bile salt is 
catalyzed by BSH. BSH (or known as cholyglycine hydrolase; EC 3.5.1.24) is the 
enzyme that catalyzes the hydrolysis of glycine- and/or taurine-conjugated bile salts 
into amino acid residues and free bile acids (Kim et al., 2004). Deconjugation of bile 
salts mainly occurs in the small and large intestines of mammalian host. However, 
the exact location of this metabolite activity is dependent on the distribution of the 
host species. For example, bile salt deconjugation starts in the small intestine of mice 
whereas a significant deconjugation in humans begins at the end of the ileum and 
completed in the large bowel (Tanaka et al., 2000). BSH activity has been detected in 
intestinal bacteria such as Lactobacillus and Bifidobacterium sp. (Liong and Shah, 
2005c). It has been demonstrated previously that the removal of cholesterol by L. 
reuteri CRL 1098 was closely related to the BSH activity of the cells which 
hydrolysed the amide bond of bile salts releasing free bile acids (Taranto et al., 
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1999). The mechanism of actions of BSH on bile is shown in Figure 2.1A. 
Conjugated bile salts are readily to be absorbed into gastrointestinal tract due to 
higher hydrophilicity, while free bile acids are less soluble and thus less efficiently 
reabsorbed into the intestines compared to conjugated bile salts, and thus are more 
prone to be excreted into faeces. This will increase the need for the synthesis of new 
bile to replace the loss. Cholesterol is the precursor for the de novo synthesis of new 
bile acids (Kumar et al., 2012; Figure 2.1B). The use of cholesterol to synthesis new 
bile would lead to a decrease concentration of cholesterol in blood. Considering that 
this mechanism involves physiological assessments, the applicability of in vitro 
experimental data to the in vivo systems needs to be justified.  
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                                                                                     (A)                                                                                                (B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Postulated mechanism of BSH on bile (A) and the role of cholesterol as the precursor for synthesis of new bile acids (B) 
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2.2.6 Conversion of cholesterol to coprostanol 
The microbial transformation of cholesterol to coprostanol mainly occurs in the 
large intestine of many species (Ma, 2006). It has been found that Bifidobacterium sp., 
Clostridium sp., and Bacteroides spp. were the common intestinal bacteria responsible 
for the transformation of cholesterol to coprostanol. Reduction of cholesterol to 
coprostanol is catalyzed by cholesterol reductase. The main metabolite of cholesterol 
conversion is coprostanol (Benno et al., 2005), which is rarely absorbed in the intestine 
and is often excreted into the faeces. In addition, an inverse relationship has been 
observed between serum cholesterol levels and the coprostanol/cholesterol ratio in 
faeces. Thus, the conversion of cholesterol to coprostanol has been considered a natural 
means of lowering serum cholesterol levels in humans (Gerard et al., 2007). Viega et al. 
(2005) reported that intestinal bacteria almost completely converted cholesterol to 
coprostanol in the intestines. However, little information is available on such an 
occurrence on lactobacilli and bifidobacteria, and the ability of lactobacilli strains to 
produce cholesterol reductase is yet to be elucidated. 
 
2.3 In vivo studies on hypocholesterolaemic effect of lactobacilli and bifidobacteria2 
 
Past in vivo trials have provided the experimental evidence to support the roles of 
lactobacilli and bifidobacteria in lowering serum cholesterol and improving lipid 
profiles. Kieling et al. (2002) used a randomized, crossover, and placebo-controlled 
design trial involving 29 women to evaluate the hypocholesterolaemic effect of yoghurt 
supplemented with L. acidophilus 145 and B. longum 913. The crossover study of 21 
weeks involved the administration of 300g per day yoghurt, and the results obtained 
2 Parts of section 2.3 have been published in: Lye, H. S., Kuan, C. Y., Ewe, J. A., et al. (2009) 
International Journal of Molecular Science, 10, 3755-3775. 
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showed that HDL-cholesterol was increased significantly (P < 0.05) by 0.3 mmol L-1 and 
the ratio of LDL/HDL cholesterol decreased from 3.24 to 2.48. Sindhu and Khetarpaul 
(2003) conducted another placebo-controlled study to evaluate the effects of a probiotic 
fermented food on serum cholesterol levels in 20 young Swiss mice. The experimental 
group was fed a food mixture containing probiotics and 1% cholesterol while the control 
group was fed food without probiotics but containing 1% cholesterol for 42 days. The 
authors reported that the feeding of L. casei NCDC-19 (109 CFU) and Saccharomyces 
boulardii (109 CFU) caused a 19% reduction in the total serum cholesterol while LDL 
cholesterol levels was reduced by 37% upon 42 days of the feeding trial. In another 
study, De Rodas et al. (1996) used a placebo-controlled design trial that involved 33 
hypercholesterolaemia-induced pigs (Yorkshire barrows) to examine the 
hypocholesterolaemic effect of probiotic. The authors reported that pig fed with L. 
acidophilus ATCC 43121 (2.5 X 1011 cells per feeding) for 15 days showed a reduced 
total blood cholesterol by 11.8% compared to the control that was not fed the probiotic. 
These positive clinical and experimental evidences have shown that probiotics could 
reduce serum cholesterol levels. Thus, further evaluation is needed to better comprehend 
the mechanisms involved.  
 
2.4 Other compounds/ dietary substances that reduce cholesterol 
Past in vivo studies have reported that other compounds/dietary substances were 
able to reduce cholesterol levels in human and animal models. Pande et al. (2012) used a 
placebo-controlled study to evaluate the effects of dietary cluster beans (Cyamopsis 
tetragonoloba) on serum cholesterol levels in 60 male Wistar rats. The authors reported 
that rats fed with 12.5% and 25% freeze dried cluster beans either on high cholesterol 
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diet (0.5%) or basal control diet for 8 weeks showed an increase in HDL cholesterol 
level compared to the control that was not fed the freeze dried cluster beans. These data 
showed that cluster beans have a cholesterol lowering potential in both normal and 
hypercholesterolaemic conditions. Kristensen et al. (2012) conducted another 
randomized, crossover, and double blind design trial that involved 17 subjects (10 
women and 7 men) to examine the effect of flaxseed dietary fibers in different food 
matrices on lipid profile. Subjects consumed with flaxseed fibre drink (3/day; 19.3% 
dietary fiber) showed a decreased in total cholesterol and LDL cholesterol by 12% and 
15%, respectively compared to the control while a reduction of 7% in total cholesterol 
and 9% in LDL cholesterol were observed with subjects consumed flaxseed fiber bread 
(3/day; 19.3% dietary fiber). In another study, Matsui et al. (2006) used a placebo-
controlled study involving 21 male Wistar rats to evaluate the hypocholesterolaemic 
effect of catechin-free saponin-rich extract from green tea leaves (TE). The results 
obtained showed that TE supplementation for 28 days reduced the serum cholesterol 
level of hypercholesterolaemia-induced rats and enhanced their faecal cholesterol 
excretion. The authors also found that TE was able to inhibit the incorporation of 
cholesterol into micelles in in vitro experiment. Thus, TE might be exhibited the 
hypocholesterolaemic effect probably through inhibiting cholesterol micelles formation 
by preventing cholesterol incorporation and subsequently reduces its absorption from the 
intestine. These positive clinical and experimental evidences have shown that dietary 
substances could have the ability to reduce serum cholesterol levels, however, they do 
not possess additional “live” benefits as those exerted by probiotics. Other “live” 
benefits of probiotics that have been reported include alleviation of lactose intolerance, 
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antibacterial, preventing gut inflammation, and enhancing natural immunity (Liu et al., 
2007). 
 
2.5 Administration of physical treatments  
Cell poration and cell fusion are important biological methods which have a wide 
variety of applications, including gene transfection, drug delivery, antibody production, 
and cell hybridization (Chang, 1989). Physical treatments such as ultrasound, 
electroporation, and UV radiation have been applied to increase permeability and 
diffusion across membrane of bacterial cells. These have been found to increase the 
uptake of nutrients and excretion of waste that further increase the growth of bacteria in 
medium. Physical methods are advantageous as they could prevent biological and 
chemical damages that occur in conventional treatments. The utilization of physical 
treatment has been found to increase fusion and transfection yield compared to treatment 
using chemical and biological methods (Chang, 1989). Thus, many studies have been 
done to evaluate the effect of physical treatment on cells and tissues, laboratory animals, 
and human subjects. The overall effects of physical treatments on bacterial cells are 
shown in Figure 2.2. However, no attempt has been made to utilize such treatments to 
enhance and/or evaluate the cholesterol removal properties of lactobacilli, either via 
assimilation of cholesterol during growth or incorporation of cholesterol into the 
bacterial membrane. 
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2.5.1 Introduction 
2.5.1.1 Ultrasound treatment 
Ultrasound can be divided into two categories based on frequency levels, namely high 
frequency-low power ultrasound (2-10 MHz) and low frequency-high power ultrasound 
(20-100 kHz). Ultrasound is often applied to increase membrane permeability in order to 
release intracellular enzymes and organelles that are used in industry and medicine 
(Rokhina et al., 2009). The effect of ultrasound on cells is dependent on strength and 
frequency of waves, cell wall structure, and treatment environment (Tabatabaie and 
Mortazavi, 2008). 
Cavitation or oscillations of bubbles is a principal effect of low frequency 
ultrasound and has been reported to be responsible for many biophysical effects on cells 
(Richardson et al., 2007). Cavitation involves a series of dynamic courses such as 
vibration, enlargement, shrinking, and even collapse of bubbles occurring during 
ultrasound treatment (Yang et al., 2010). Repeatable oscillation of bubbles without 
implosion at low intensity forms stable cavitation (Runyan et al., 2006) and is often 
harmless. However, when the intensity of ultrasound increases, the size of bubbles near 
the resonant size for the applied frequency starts to oscillate nonlinearly and eventually 
collapse (Richardson et al., 2007). The collapse of bubbles results in a violent implosion 
that produces a shock wave that breaks cellular and membrane chemical bonds. This 
membrane structural alteration of cells subsequently affects the functionality of the cell 
membrane and metabolism activities (Tabatabaie and Mortazavi, 2008). 
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Figure 2.2: Postulated effects of physical treatments on bacteria cell. 
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